Recent Advances in Health Biotechnology During Pandemic
![Thumbnail](/xmlui/bitstream/handle/11352/4593/Yuka.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2023Author
Yuka, Selcen ArıAkpek, Ali
Özarslan, Alican
Vural, Alperen
Koçer, Anıl Tevfik
Aslan, Ayça
Karaaltın, Ayşegül B.
Gök, Bahar
Yılmaz, Begüm Bahar
İnan, Benan
Mutlu, Betül
Karacaoğlu, Beyza
Doymuş, Burcu
Üstündağ, Cem Bülent
Özel, Cem
Özçimen, Didem
Çakan, Doğan
Yetişkin, Eda Nur Morgan
Akyol, Emel
Karaduman, Emre
Çiftçi, Fatih
Peközer, Görke Gürel
Karaca, Gülcan Ayşin
Amasya, Hakan
Demir, Hatice
Çalık, Hilal
Üvet, Hüseyin
Orhan, Kaan
Daaboul, Maria
Pişkin, Mehmet Burçin
Topuzoğullar, Murat
Aydın, Nuri
Gündüz, Oğuzhan
Küçük, Osman
Kürtür, Ozan Barış
Çakır, Rabia Koç
Önder, Sakip
Yücel, Sevil
Alhamwi, Shifa
Şimşek, Sinan
Birant, Sinem
Ulağ, Songül
Kaya, Süheyla
Ayan, Sümeyra
Özer, Tuğba
Kılınç, Yasemin Budama
Elalmış, Yeliz Başaran
Yılmaz, Yetkin Zeki
Metadata
Show full item recordCitation
YUKA, Selcen Arı, Ali AKPEK, Alican ÖZARSLAN, Alperen VURAL, Anıl Tevfik KOÇER, Ayça ASLAN, Ayşegül B. KARAALTIN, Bahar GÖK, Begüm Bahar YILMAZ, Benan İNAN, Betül MUTLU, Beyza KARACAOĞLU, Burcu DOYMUŞ, Cem Bülent ÜSTÜNDAĞ, Cem ÖZEL, Didem ÖZÇİMEN, Doğan ÇAKAN, Eda Nur MORKAN, Emel AKYOL, Emre KARADUMAN, Fatih ÇİFTÇİ, Görke GÜREL PEKÖZER, Gülcan Ayşin KARACA, Hakan AMASYA, Hatice DEMİR, Hilal ÇALIK, Hüseyin ÜVET, Kaan ORHAN, Maria DAABOUL, Mehmet Burçin PİŞKİN, Murat TOPUZOĞULLAR, Nuri AYDIN, Oğuzhan GÜNDÜZ, Osman KÜÇÜK, Ozan Barış KÜRTÜR, Rabia ÇAKIR KOÇ, Sakip ÖNDER, Sevil YÜCEL, Shifa ALHAMWİ, Sinan ŞİMŞEK, Sinem BİRANT, Songül ULAĞ, Süheyla KAYA, Sümeyra AYAN, Tuğba ÖZER, Yasemin BUDAMA KILINÇ, Yeliz BAŞARAN ELALMIŞ, Yetkin Zeki YILMAZ. " Recent Advances in Health Biotechnology During Pandemic". Sigma Journal of Engineering and Natural Sciences, 41.3. (2023):625-655.Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which
emerged in 2019, cut the epoch that will make profound fluctuates in the history of the world
in social, economic, and scientific fields. Urgent needs in public health have brought with
them innovative approaches, including diagnosis, prevention, and treatment. To exceed the
coronavirus disease 2019 (COVID-19) pandemic, various scientific authorities in the world
have procreated advances in real time polymerase chain reaction (RT-PCR) based diagnostic
tests, rapid diagnostic kits, the development of vaccines for immunization, and the purposing
pharmaceuticals for treatment. Diagnosis, treatment, and immunization approaches put for-
ward by scientific communities are cross-fed from the accrued knowledge of multidisciplinary
sciences in health biotechnology. So much so that the pandemic, urgently prioritized in the
world, is not only viral infections but also has been the pulsion in the development of novel
approaches in many fields such as diagnosis, treatment, translational medicine, virology, mi-
crobiology, immunology, functional nano- and bio-materials, bioinformatics, molecular biol-
ogy, genetics, tissue engineering, biomedical devices, and artificial intelligence technologies.
In this review, the effects of the COVID-19 pandemic on the development of various scientific
areas of health biotechnology are discussed.